Clinical Trial Update: Revacept in Symptomatic Carotid Stenosis [Phase 2]

View source ↗

Summary

Phase 2 trial update for Revacept in symptomatic carotid stenosis; results completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amaurosis Fugax
• Atherosclerosis
• Carotid Stenosis
• Stroke
• Tia
• Transient Ischemic Attack

Drugs mentioned

• Revacept (revacept)

Snippet

Sponsor: AdvanceCor GmbH | Conditions: Carotid Stenosis, Atherosclerosis | Phase 2 | Status: COMPLETED | Results posted: 2021-01-28